150 results on '"van de Meeberg, Paul C."'
Search Results
2. The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naïve Inflammatory Bowel Disease Patients
3. No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies
4. Pre-to-post diagnosis weight trajectories in colorectal cancer patients with non-metastatic disease
5. Risk factors of work disability in patients with inflammatory bowel disease — A Dutch nationwide web-based survey: Work disability in inflammatory bowel disease
6. Equivalent Helicobacter pylori infection rates in Lynch syndrome mutation carriers with and without a first-degree relative with gastric cancer
7. Increased Belching After Sleeve Gastrectomy
8. POOLING BARRETT'S ESOPHAGUS (BE) SURVEILLANCE ENDOSCOPIES ON DEDICATED LISTS IMPROVES ADHERENCE TO THE FOUR-QUADRANT (4Q) RANDOM BIOPSY PROTOCOL
9. Clinical Predictors of Future Nonadherence in Inflammatory Bowel Disease
10. Association Between Postprandial Symptoms and Gastric Emptying After Sleeve Gastrectomy
11. Effect of Sleeve Gastrectomy on Gastroesophageal Reflux
12. One to 2-Year Surveillance Intervals Reduce Risk of Colorectal Cancer in Families With Lynch Syndrome
13. Fish consumption and markers of colorectal cancer risk: a multicenter randomized controlled trial
14. Healthy cotwins share gut microbiome signatures with their inflammatory bowel disease twins and unrelated patients
15. Increased consumption of fatty and lean fish reduces serum C-reactive protein concentrations but not inflammation markers in feces and in colonic biopsies
16. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study
17. Su510 HEALTHY COTWINS SHARE GUT MICROBIOME SIGNATURES WITH THEIR INFLAMMATORY BOWEL DISEASE TWINS AND UNRELATED PATIENTS
18. Healthy Cotwins Share Gut Microbiome Signatures With Their Inflammatory Bowel Disease Twins and Unrelated Patients
19. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome
20. Effects of Ursodeoxycholic Acid Therapy on In Vitro Gallbladder Contractility in Patients with Cholesterol Gallstones
21. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome
22. Increasing fish consumption does not affect genotoxicity markers in the colon in an intervention study
23. Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses
24. Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response
25. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF alpha therapy
26. Pre-to-post diagnosis weight trajectories in colorectal cancer patients with non-metastatic disease
27. Smoking is Associated with Higher Disease-related Costs and Lower Health-related Quality of Life in Inflammatory Bowel Disease
28. Clinical Predictors of Future Nonadherence in Inflammatory Bowel Disease
29. Smoking is Associated with Higher Disease-related Costs and Lower Health-related Quality of Life in Inflammatory Bowel Disease
30. Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up
31. Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up
32. Effect of Aging on Healthcare Costs of Inflammatory Bowel Disease: A Glimpse into the Future
33. Su1801 One Simple Question Is Sufficient for Measuring Medication Adherence in Inflammatory Bowel Disease Patients Using Self-Report
34. Sa1944 Non-Adherence to Medical Therapy Is Associated With Hospitalizations and the Development of Active Disease in Inflammatory Bowel Disease
35. Sa1945 Lower Quality of Life, More Active Disease and Increased Healthcare Costs Due to Non-Adherence in Inflammatory Bowel Disease
36. Self-reported disability in patients with inflammatory bowel disease largely determined by disease activity and illness perceptions
37. Self-reported disability in patients with inflammatory bowel disease largely determined by disease activity and illness perceptions
38. Comparison of Costs and Quality of Life in Ulcerative Colitis Patients with an Ileal Pouch–Anal Anastomosis, Ileostomy and Anti-TNFα Therapy
39. Increased Belching After Sleeve Gastrectomy
40. Su1300 Healthcare Expenditures for Inflammatory Bowel Disease Peak in Patients With a Short Disease Duration
41. Tu1243 Evolution of IBD-Related Costs Over Two Years of Follow up: Increase of Anti-TNF α Therapy Related Costs With a Decline of Hospitalization Costs
42. Su1299 Smoking Is Associated With Extra-Intestinal Manifestations in Inflammatory Bowel Disease
43. Sa1155 Smoking Is Associated With Higher Healthcare Costs in IBD Patients, Primarily Due to More Frequent Anti-TNFα Use
44. Self-reported Disability in Patients with Inflammatory Bowel Disease Largely Determined by Disease Activity and Illness Perceptions
45. Effect of aging on healthcare costs of inflammatory bowel disease: A glimpse into the future
46. Association Between Postprandial Symptoms and Gastric Emptying After Sleeve Gastrectomy
47. Nocturnal and daytime esophageal acid exposure in normal-weight, overweight, and obese patients with reflux symptoms
48. Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up.
49. Quality of Life After Surgery for Colon Cancer in Patients With Lynch Syndrome
50. Sa1285 Is There a Difference in Quality of Life and Costs Between Ulcerative Colitis Patients With a Pouch or an Ileostomy?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.